Nvidia-backed AI biotech Iambic Therapeutics files for IPO

Iambic Therapeutics has filed to go public, the latest example in the maturation of the next crop of AI-focused biotech startups. The San Diego-based company disclosed new details on its own pipeline programs and pharma ...

endpoints.news ·2026-09-22

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing seekingalpha.com

Read the original at endpoints.news →

More in AI

America’s AI Safety Dilemma and at the Trump-Xi Summit

Washington will not slow its own AI labs. Slowing China’s instead would look like safety policy, but it could cost the United States the one AI deal within reach this week.

2026-09-22 ·thediplomat.com

Amazon's block on Meta agent

A Amazon deu um block no Muse, o novo agente de AI da Meta. O Muse, um assistente de AI que pode ser usado pelas pessoas para automatizar atividades corriqueiras como compras online e envio de emails, vem ganhando adeptos rapidamente desde seu lançamento duas semanas atrás.

2026-09-22 ·braziljournal.com

Nvidia-backed AI biotech Iambic Therapeutics files for IPO

This story

More in AI

America’s AI Safety Dilemma and at the Trump-Xi Summit

Amazon's block on Meta agent

3 AI Stocks Expected to Triple Revenue in the Coming Years

These 2 Companies Are Quietly Powering the AI Boom. No, It's Not Nvidia or Palantir.

AI assistant learns from radiology reports to spot problems in abdominal scans

Jev – a curation of Jev demos on X, tools, skills, and integrations